Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
Moorfields Eye Hospital NHS Foundation Trust · University of Oxford · +13 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
776
total citations
- FWCI
- 45.24
- Percentile
- 100%
- References
- 30
Citations per year
Authors
14- RERobert E. MacLarenCorresponding
Moorfields Eye Hospital NHS Foundation Trust, University of Oxford, Oxford BioMedica (United Kingdom), Oxford University Hospitals NHS Trust
- MGMarkus Groppe
Moorfields Eye Hospital NHS Foundation Trust, University of Oxford, Oxford BioMedica (United Kingdom), Oxford University Hospitals NHS Trust
- ARAlun R. Barnard
University of Oxford
- CLCharles L. Cottriall
Oxford University Hospitals NHS Trust
- TTTanya Tolmachova
Imperial College London
Topics & keywords
Topics
Keywords
- Choroideremia
- Microperimetry
- Visual acuity
- Medicine
- Ophthalmology
- Retinal
- Genetic enhancement
- Clinical trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.